Candel Therapeutics, Inc.
Candel Therapeutics, Inc.（CADL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cadl · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$15.00
Consensus
$15.00
+76.0% upside
Low
$15.00
Median: $15 · Last Close: $8.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.81 | ↑ 3.34% |
1-day model range: $8.73–$8.89. Peak: $8.89 (+3.34%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $7 | -14.1% |
| 2028 | $7 | -20.8% |
| 2029 | $6 | -24.2% |
| 2030 | $6 | -26.0% |
| 2031 | — | -26.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CADL · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-18 | Citigroup | Maintains | Buy→Buy |
| 2026-03-13 | Citigroup | Maintains | Buy→Buy |
| 2026-03-13 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-12-08 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-11-21 | Freedom Broker | Maintains | Buy→Buy |
| 2025-11-14 | Citigroup | Maintains | Buy→Buy |
| 2025-09-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-03 | B of A Securities | Downgrade ↓ | Buy→Neutral |
| 2025-04-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Candel Therapeutics, Inc. (CADL) stock. Of the recent 26 rating actions, 0 were upgrades and 1 were downgrades. 10 analysts currently cover CADL.
分析师推荐趋势
CADL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$93M
↓ 42.2% YoY
Revenue Next Year
$42M
↓ 54.6% YoY
EPS This Year
$-0.94
EPS Next Year
$-0.67
↓ 28.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast CADL EPS of $-0.94 for the current fiscal year, based on estimates from 4 analysts. The CADL revenue forecast is $93M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CADL 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CADL 的共识目标价为 $15.00（+76.0% 上行空间），分析师共识为 Buy。
CADL 的短期预测（明日）为 $8.81（+3.34%）。 CADL 对 2027 年的股价预测均值为 $7。 CADL 对 2030 年的预测区间为 $6–$7。
Candel Therapeutics, Inc. 在 NASDAQ 上市，代码 CADL。CADL 在 2027 年的整体展望偏积极，在覆盖分析师中约 90% 对应 Buy 共识。
常见问题
CADL 预测 · 8 个问题根据 10 位华尔街分析师，CADL 的 12 个月平均目标价为 $15.00，最高 $15.00、最低 $15.00。若有图表，中位目标价可在上方查看。相对当前价 $8.53，隐含约 +76.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.